Joseph Thome
Stock Analyst at TD Cowen
(1.67)
# 3,398
Out of 5,179 analysts
22
Total ratings
47.37%
Success rate
-5.15%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Joseph Thome
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| MIRM Mirum Pharmaceuticals | Maintains: Buy | $117 → $125 | $88.44 | +41.34% | 3 | Mar 27, 2026 | |
| UTHR United Therapeutics | Maintains: Buy | $525 → $575 | $522.83 | +9.98% | 3 | Feb 26, 2026 | |
| PTCT PTC Therapeutics | Maintains: Hold | $50 → $63 | $66.13 | -4.73% | 3 | Nov 5, 2025 | |
| ARDX Ardelyx | Maintains: Buy | $9 → $10 | $5.48 | +82.48% | 1 | Oct 31, 2025 | |
| DRUG Bright Minds Biosciences | Initiates: Buy | n/a | $70.10 | - | 1 | May 13, 2025 | |
| VRDN Viridian Therapeutics | Initiates: Buy | n/a | $27.39 | - | 1 | Nov 25, 2024 | |
| RAPP Rapport Therapeutics | Initiates: Buy | n/a | $27.84 | - | 1 | Jul 2, 2024 | |
| ALKS Alkermes | Initiates: Buy | $34 | $29.39 | +15.69% | 1 | Jun 17, 2024 | |
| PRME Prime Medicine | Initiates: Buy | n/a | $3.38 | - | 1 | Apr 8, 2024 | |
| MGX Metagenomi Therapeutics | Initiates: Outperform | n/a | $1.32 | - | 1 | Mar 5, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Outperform | n/a | $54.48 | - | 1 | Dec 12, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Outperform | n/a | $1.33 | - | 1 | Dec 12, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $120 → $130 | $156.35 | -16.85% | 2 | Jun 29, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Outperform | n/a | $12.37 | - | 1 | Jan 31, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Outperform | n/a | $11.93 | - | 1 | Nov 23, 2021 |
Mirum Pharmaceuticals
Mar 27, 2026
Maintains: Buy
Price Target: $117 → $125
Current: $88.44
Upside: +41.34%
United Therapeutics
Feb 26, 2026
Maintains: Buy
Price Target: $525 → $575
Current: $522.83
Upside: +9.98%
PTC Therapeutics
Nov 5, 2025
Maintains: Hold
Price Target: $50 → $63
Current: $66.13
Upside: -4.73%
Ardelyx
Oct 31, 2025
Maintains: Buy
Price Target: $9 → $10
Current: $5.48
Upside: +82.48%
Bright Minds Biosciences
May 13, 2025
Initiates: Buy
Price Target: n/a
Current: $70.10
Upside: -
Viridian Therapeutics
Nov 25, 2024
Initiates: Buy
Price Target: n/a
Current: $27.39
Upside: -
Rapport Therapeutics
Jul 2, 2024
Initiates: Buy
Price Target: n/a
Current: $27.84
Upside: -
Alkermes
Jun 17, 2024
Initiates: Buy
Price Target: $34
Current: $29.39
Upside: +15.69%
Prime Medicine
Apr 8, 2024
Initiates: Buy
Price Target: n/a
Current: $3.38
Upside: -
Metagenomi Therapeutics
Mar 5, 2024
Initiates: Outperform
Price Target: n/a
Current: $1.32
Upside: -
Dec 12, 2022
Initiates: Outperform
Price Target: n/a
Current: $54.48
Upside: -
Dec 12, 2022
Initiates: Outperform
Price Target: n/a
Current: $1.33
Upside: -
Jun 29, 2022
Maintains: Outperform
Price Target: $120 → $130
Current: $156.35
Upside: -16.85%
Jan 31, 2022
Initiates: Outperform
Price Target: n/a
Current: $12.37
Upside: -
Nov 23, 2021
Initiates: Outperform
Price Target: n/a
Current: $11.93
Upside: -